In what clinical situations is the calcium‑creatinine ratio performed?

Calcium-Creatinine Ratio: Clinical Applications

The calcium-creatinine ratio is performed primarily to screen for and monitor hypercalciuria in children and adults, particularly in the evaluation of urolithiasis, unexplained hematuria, Williams syndrome, X-linked hypophosphataemia (XLH), and during treatment with vitamin D metabolites or calcium-based therapies.

Primary Clinical Indications

Pediatric Populations

Hypercalciuria screening is the most established indication for calcium-creatinine ratio testing. The test should be performed in children presenting with:

• Urolithiasis (kidney stones) 1, 2
• Unexplained hematuria 2, 3, 4
• Urinary tract symptoms including dysuria, frequency, urgency, abdominal/flank pain, diurnal incontinence, or enuresis 3
• Recurrent urinary tract infections 3

The evidence strongly supports that urinary calcium-creatinine ratio is significantly elevated in children with all types of urinary symptoms, with one study finding 31.3% of symptomatic children had hypercalciuria 3.

Williams Syndrome Management

The urine calcium/creatinine ratio in a random spot urine should be obtained at the time of diagnosis and if hypercalcemia is present 1. In Williams syndrome specifically:

• Obtain the ratio every 4-6 months until age 2 years
• Continue every 2 years thereafter
• Test when hypercalcemia is suspected clinically
• If hypercalciuria is found, assess hydration status, measure serum calcium, evaluate dietary calcium intake, and perform renal ultrasonography to screen for nephrocalcinosis 1

X-Linked Hypophosphataemia (XLH)

Measure calcium and creatinine levels in urine to calculate the urinary calcium:creatinine ratio in patients on conventional or burosumab treatment 5, 6. The monitoring schedule includes:

• Twice-yearly monitoring in all XLH patients 5
• Kidney ultrasonography at least every 2 years in patients without nephrocalcinosis
• Yearly intervals in patients with nephrocalcinosis and/or persistent hypercalciuria 5

Age-specific upper normal limits for urinary calcium-creatinine ratio (mol/mol) are: <1 year: 2.2; 1-3 years: 1.4; 3-5 years: 1.1; 5-7 years: 0.8; 7-18 years: 0.7; >18 years: 0.57 6.

Diagnostic Thresholds and Interpretation

Hypercalciuria Diagnosis

A calcium-creatinine ratio >0.2 mg/mg is generally considered diagnostic of hypercalciuria 2, 3. However, the optimal cutoff varies by study:

• 0.23 mg/mg showed strong correlation with 24-hour calcium excretion >4 mg/kg/day 2
• 0.075 mg/mg provided 77.8% sensitivity and 64.3% specificity in children with hematuria 4

Sample Timing Considerations

Evening and first morning spot urine samples provide the strongest correlation with 24-hour urinary calcium excretion 7. The correlation coefficients were:

• Evening sample: 0.64
• First morning sample: 0.71
• Second morning sample: 0.52

This means the first morning void is optimal for screening purposes 7.

Monitoring During Treatment

Vitamin D Therapy

The calcium-creatinine ratio is a simple test for early detection of hypercalciuria in patients with long-term administration of vitamin D metabolites 2. This is particularly important because:

• Vitamin D supplementation should be used with caution in children with Williams syndrome 1
• Multivitamin preparations containing vitamin D should be avoided in early childhood in Williams syndrome 1

Secondary Hyperparathyroidism

In vitamin D-dependent rickets type 1A (VDDR1A), a urinary calcium-creatinine ratio <0.1 mg/mg indicates calcium depletion and secondary hyperparathyroidism, helping determine proper alfacalcidol dosing 8. However, body calcium status (depletion vs. excess) must be considered for accurate interpretation.

Important Caveats and Limitations

When 24-Hour Collection is Preferred

Despite the convenience of spot urine testing, 24-hour urinary analysis should be performed to definitively diagnose hypercalciuria in children with hematuria 4. One study found that random urinary calcium-creatinine ratio was not suitable for screening hypercalciuria in this specific population, with only moderate correlation (r=0.584) to 24-hour excretion 4.

Factors Affecting Interpretation

The calcium-creatinine ratio can be influenced by:

• Hydration status - must be assessed when hypercalciuria is detected 1
• Dietary calcium intake - should be evaluated concurrently 1
• Body mass index - significantly affects the ratio 4
• Timing of collection - evening and first morning samples are most reliable 7

Race and Age Considerations

Normal reference ranges differ significantly by race and age. For 24-hour urine calcium (which correlates with the ratio), the 95% reference intervals are 9:

• Black older women: 7-225 mg
• Black younger women: 8-285 mg
• White older women: 37-275 mg
• White younger women: 23-287 mg

Clinical laboratories using outdated normal ranges of 100-300 mg need to update their age- and race-specific reference intervals 9.

Practical Clinical Algorithm

1. Initial screening: Obtain first morning or evening spot urine for calcium-creatinine ratio
2. If ratio >0.2 mg/mg: Assess hydration, dietary calcium intake, and serum calcium
3. If hypercalciuria confirmed: Perform renal ultrasonography for nephrocalcinosis
4. If persistent or symptomatic: Consider 24-hour urine collection for definitive diagnosis
5. If on vitamin D therapy: Monitor ratio regularly to detect early hypercalciuria
6. If ratio <0.1 mg/mg in VDDR1A: Consider calcium depletion and adjust alfacalcidol dose

The calcium-creatinine ratio serves as a practical, non-invasive screening tool that avoids the challenges of 24-hour urine collection in children, though its limitations must be recognized in specific clinical contexts 2, 4.